Only a few cases of pityriasis rosea (PR)/pityriasis rosea-like eruption (PRLE) after anti-SARS-CoV-2 vaccination have been reported. Please enable it to take advantage of the complete set of features! Herald patch of pityriasis rosea. Pityriasis rosea is generally benign and most of the time will not come back after a patient has recovered, but in a small number of cases the condition recurs which may be a sign, there is another underlying condition causing the rash.. Bathe or shower in lukewarm water. All patients are currently in good general health. Before 8:752443. doi: 10.3389/fmed.2021.752443. 10.1007/S10354-021-00876-0 Cyrenne BM, Al-Mohammedi F, DeKoven JG, Alhusayen R. J Eur Acad Dermatol Venereol. National Library of Medicine Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine Pityriasis rosea (PR) is an acute papulosquamous cutaneous disorder that classically presents with a herald patch rapidly followed by a widespread rash along skin cleavage lines. Suchonwanit P, Hector CE, Bin Saif GA, McMichael AJ. 2022 Jul 6;15(1):9503. doi: 10.4081/dr.2022.9503. J Eur Acad Dermatol Venereol. Careers. Unable to load your collection due to an error, Unable to load your delegates due to an error. Pityriasis Rosea | Johns Hopkins Medicine The significance of investigating clinical, histopathologic and virological features in pityriasis rosea and pityriasis rosea-like eruptions following COVID-19 vaccinations. 8600 Rockville Pike Abstract Dear Editor, Pityriasis rosea (PR) is a common, self-limited erythematous papulosquamous dermatosis that mainly affects young adults. Pityriasis versicolor is another common skin condition that can be confused with pityriasis rosea, as the rash may look similar. The site is secure. FOIA Clipboard, Search History, and several other advanced features are temporarily unavailable. doi: 10.1111/dth.13878, 10. 2023 Apr;11(4):e804. 2022 Feb 3;9 (2):003164. doi: 10.12890/2022_003164. The patient developed papulovesicular lesions in the crease lines of the trunk and extremities, four days after inoculation with a recombinant coronavirus vaccine (Covishield, India). Before The duration of the infection ranges from two weeks to three months. J Eur Acad Dermatol Venereol 2016; 30: 544-545. Pityriasis rosea after Moderna mRNA-1273 vaccine: A case series. Patient n. 1. All authors have made substantial contribution to the work and have approved the final version of this article. Keywords: The following self-care tips may help relieve the discomfort of pityriasis rosea: Take nonprescription allergy medicine (antihistamines), such as diphenhydramine (Benadryl, others).
Pathfinder Kingmaker Uncanny Well, Articles P